Diagnostics News and Research

RSS

Immunosignature technique provides pre-symptomatic diagnosis for broad range of ailments

An inexpensive system for earlier disease diagnosis could save innumerable lives. It would also have a profound impact on the nation's healthcare industry, currently buckling under the strain of spiraling costs.

9 Jun 2010

Clarient granted U.K. patent for TLE3 biomarker

Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that the United Kingdom Patent Office has granted a U.K. patent on the Company's TLE3 biomarker, a marker which may be used to predict which cancer patients will respond favorably to taxane therapy.

8 Jun 2010

Form of epigenetics may play role in pulmonary arterial hypertension: Researchers

A rare but fatal disease of blood vessels in the lung may be caused in part by aberrant silencing of genes rather than genetic mutation, new research reports. Pulmonary arterial hypertension, a syndrome characterized by gradual blockage of blood vessels in the lungs, has been linked to genetic causes in a small percentage of patients. But University of Chicago researchers have now found that a form of epigenetics - the modification of gene expression - causes the disease in an animal model and could contribute to the disease in humans.

8 Jun 2010

QBC Diagnostics launches SureFocus Microscope Slide for detection of tuberculosis bacteria

QBC Diagnostics is pleased to announce the release of the SureFocus Microscope Slide, a breakthrough in the detection of tuberculosis bacteria.

8 Jun 2010

B2Discovery rallies business leaders in support of excellence in cancer research

The Institute for Research in Immunology and Cancer (IRIC) of the Universit- de Montr-al launches B2Discovery, a new research funding model that brings together the private sector and the biomedical research community to help accelerate the discovery of new anti-cancer therapeutics. Inspired by B2ten, which contributed to the success of several Canadian athletes at the Vancouver Winter Olympics, B2Discovery's mission is to partner entrepreneurs with IRIC's cancer investigators to finance novel and promising research projects not currently funded by public granting agencies.

7 Jun 2010

Chronix's serum DNA assays have potential to detect early stage breast cancer, prostate cancer

Chronix Biomedical today reported new data further demonstrating that its serum DNA blood tests have the potential to accurately detect early stage breast cancer and prostate cancer. Chronix's proprietary technology identifies disease-specific genetic fingerprints based on circulating DNA fragments that are released into the bloodstream by damaged and dying (apoptotic) cells.

7 Jun 2010

Biomoda granted Mexican patent for proprietary porphyrin-based compound

Cancer diagnostics company Biomoda, Inc. has been granted a Mexican patent for its proprietary porphyrin-based compound that binds to cancer cells and causes them to fluoresce red under ultraviolet light.

7 Jun 2010

Medivo announces acquisition of PWN

Medivo, a provider of virtual healthcare services for individuals and organizations, announced today the acquisition of Physicians Wellness Network LLC, a leading provider of compliance services for online wellness screening tests.

7 Jun 2010

Multiple study data on Agendia's MammaPrint, BluePrint, and ColoPrint assays to be presented at 2010 ASCO

Agendia, a world leader in molecular cancer diagnostics, today announced that researchers from Agendia and leading academic centers in the U.S. and Europe will present data from multiple studies concerning Agendia's assays MammaPrint(R), BluePrint(TM), and ColoPrint(TM) at the American Society of Clinical Oncology Annual Meeting, June 4 - 8, 2010, at McCormick Place in Chicago. MammaPrint, the company's lead product, is the only FDA-cleared breast cancer recurrence test.

5 Jun 2010

Patient Home Monitoring completes acquisition of Stancap Holdings I and PHM DME Healthcare

Patient Home Monitoring, formerly International Health Partners Inc., a company focused on in-home cardiology healthcare services, today announced completion of the acquisition announced in October 2009 of all of the issued and outstanding shares of both Stancap Holdings I Limited and PHM DME Healthcare Inc. PHM also announced that it has completed a private placement of common shares for gross proceeds of $4,523,140.

5 Jun 2010

Encore Path signs license agreement for UMB technology that helps stroke patients redevelop natural gait

The University of Maryland, Baltimore's Office of Research and Development announced that Encore Path, Inc. of Baltimore signed an exclusive worldwide license agreement for a device technology invented jointly by researchers at the University of Maryland, Baltimore and the University of Maryland Baltimore County that helps stroke patients retrain their bodies to walk.

5 Jun 2010

PEB's European licensee SDX completes clinical trial for prognostic gene signature for colorectal cancer

Pacific Edge (PEB), a New Zealand-based biomedical company, today announced the successful completion of the European clinical trial for their prognostic gene signature for colorectal cancer. The clinical trial results showed a successful outcome that enables patients diagnosed with UICC stage II or UICC stage III colorectal cancer and with a high risk of disease progression to be identified and treated more appropriately.

5 Jun 2010

ASCO 2010 marks first anniversary of "Cancer Patient Statement of Principles"

The International Myeloma Foundation (IMF), the oldest and largest foundation dedicated to improving the life and care of myeloma patients, notes the 2010 Annual Meeting of the American Society for Clinical Oncology (ASCO) marks the first anniversary of the "Cancer Patient Statement of Principles."

4 Jun 2010

Freescale Semiconductor develops portable medical kiosk to run routine health screenings at home

As the population continues to age and medical monitoring becomes more integrated into everyday living, healthcare professionals are constantly striving to find new ways to monitor patients with improved accuracy, speed and end-user convenience. Taking an active part in this initiative, Freescale Semiconductor, partnering with Pounce Consulting, developed a portable, easy-to-use telemonitoring reference design, which allows patients and physicians to run routine health screenings at home or remotely.

4 Jun 2010

Roche's new dual-PCR target HIV-1 viral load test receives FDA approval

Roche Molecular Diagnostics announced today that the Food and Drug Administration (FDA) approved its new dual-PCR target HIV-1 viral load test to quantify the amount of virus in a patient's blood. The COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test, v2.0 is the first quantitative viral load test to amplify and detect two separate regions of a target genome and offers a fully automated and reliable solution for physicians to make informed treatment decisions for HIV-1 patients undergoing antiretroviral therapy.

4 Jun 2010

Alere to introduce new global logo, brand identity at AHIP's Institute 2010

Alere Health, LLC, a leading provider of personal health support solutions to employers and health plans, announced today that it will introduce its new global logo and brand identity at AHIP's Institute 2010 in Las Vegas, June 9-11. The rollout of the new brand identity is part of a global campaign by its parent company, Inverness Medical Innovations, Inc., a global leader in rapid point-of-care diagnostics, to align the majority of its operations under the single brand, Alere.

4 Jun 2010

BSGI effective for evaluating unclear mammographic or ultrasound findings

Researchers at the Legacy Good Samaritan Hospital in Portland, Oregon presented data on the clinical use of Breast-Specific Gamma Imaging (BSGI), a molecular breast imaging technique, at the American Society of Breast Surgeons Annual meeting in Las Vegas in April: Breast Specific Gamma Imaging Used As An Adjunct to Mammography.

4 Jun 2010

WisTa Laboratories announces collaborative R&D agreement with Bayer Schering Pharma

WisTa Laboratories Ltd, a wholly owned subsidiary of TauRx Pharmaceuticals, announced today that they have entered a collaborative R&D agreement with Bayer Schering Pharma AG, Germany, which could redefine the way Alzheimer's disease (AD) and related disorders are currently being diagnosed and treated.

4 Jun 2010

FDA clears Abbott's new ARCHITECT HE4 assay for monitoring ovarian cancer

The U.S. Food and Drug Administration (FDA) has cleared a new diagnostic test to monitor ovarian cancer, a disease that will strike an estimated one out of every 71 women in the United States in their lifetimes. Abbott's new ARCHITECT HE4 (human epididymis protein 4) assay, the first automated test of its kind available in the United States, uses a simple blood test to aid in monitoring for the recurrence or progression of this disease.

4 Jun 2010

Amorfix Life Sciences signs licensing agreement with PREVENT

Amorfix Life Sciences Ltd. and Pan-Provincial Vaccine Enterprise Inc. of Saskatoon, Saskatchewan, today announced that the two groups have entered into a licensing agreement granting PREVENT exclusive worldwide rights to Amorfix's lead amyotrophic lateral sclerosis vaccines.

3 Jun 2010

Diagnostics News and Research

Immunosignature technique provides pre-symptomatic diagnosis for broad range of ailments

Clarient granted U.K. patent for TLE3 biomarker

Form of epigenetics may play role in pulmonary arterial hypertension: Researchers

QBC Diagnostics launches SureFocus Microscope Slide for detection of tuberculosis bacteria

B2Discovery rallies business leaders in support of excellence in cancer research

Chronix's serum DNA assays have potential to detect early stage breast cancer, prostate cancer

Biomoda granted Mexican patent for proprietary porphyrin-based compound

Medivo announces acquisition of PWN

Multiple study data on Agendia's MammaPrint, BluePrint, and ColoPrint assays to be presented at 2010 ASCO

Patient Home Monitoring completes acquisition of Stancap Holdings I and PHM DME Healthcare

Encore Path signs license agreement for UMB technology that helps stroke patients redevelop natural gait

PEB's European licensee SDX completes clinical trial for prognostic gene signature for colorectal cancer

ASCO 2010 marks first anniversary of "Cancer Patient Statement of Principles"

Freescale Semiconductor develops portable medical kiosk to run routine health screenings at home

Roche's new dual-PCR target HIV-1 viral load test receives FDA approval

Alere to introduce new global logo, brand identity at AHIP's Institute 2010

BSGI effective for evaluating unclear mammographic or ultrasound findings

WisTa Laboratories announces collaborative R&D agreement with Bayer Schering Pharma

FDA clears Abbott's new ARCHITECT HE4 assay for monitoring ovarian cancer

Amorfix Life Sciences signs licensing agreement with PREVENT

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News